New pain drug approved

The FDA has approved tapentadol immediate-release tablets for the relief of moderate-to-severe acute pain in adults 18 years of age or older. Tapentadol is a centrally acting oral analgesic that combines mu-opioid receptor agonism and norepinephrine reuptake inhibition. The FDA approved tapentadol tablets in 50 mg, 75 mg, and 100 mg doses. The approval was…

Next post in Clinical Challenge